314 related articles for article (PubMed ID: 25140899)
1. Deciphering the glycolipid code of Alzheimer's and Parkinson's amyloid proteins allowed the creation of a universal ganglioside-binding peptide.
Yahi N; Fantini J
PLoS One; 2014; 9(8):e104751. PubMed ID: 25140899
[TBL] [Abstract][Full Text] [Related]
2. Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides.
Di Scala C; Yahi N; Flores A; Boutemeur S; Kourdougli N; Chahinian H; Fantini J
Biochim Biophys Acta; 2016 Feb; 1862(2):213-22. PubMed ID: 26655601
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis for the glycosphingolipid-binding specificity of α-synuclein: key role of tyrosine 39 in membrane insertion.
Fantini J; Yahi N
J Mol Biol; 2011 May; 408(4):654-69. PubMed ID: 21396938
[TBL] [Abstract][Full Text] [Related]
4. Interactions of amyloid beta-protein with various gangliosides in raft-like membranes: importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid.
Kakio A; Nishimoto S; Yanagisawa K; Kozutsumi Y; Matsuzaki K
Biochemistry; 2002 Jun; 41(23):7385-90. PubMed ID: 12044171
[TBL] [Abstract][Full Text] [Related]
5. Gene Therapy Strategy for Alzheimer's and Parkinson's Diseases Aimed at Preventing the Formation of Neurotoxic Oligomers in SH-SY5Y Cells.
El-Battari A; Rodriguez L; Chahinian H; Delézay O; Fantini J; Yahi N; Di Scala C
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768981
[TBL] [Abstract][Full Text] [Related]
6. How cholesterol constrains glycolipid conformation for optimal recognition of Alzheimer's beta amyloid peptide (Abeta1-40).
Yahi N; Aulas A; Fantini J
PLoS One; 2010 Feb; 5(2):e9079. PubMed ID: 20140095
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease: NMR studies of asialo (GM1) and trisialo (GT1b) ganglioside interactions with Abeta(1-40) peptide in a membrane mimic environment.
Mandal PK; Pettegrew JW
Neurochem Res; 2004 Feb; 29(2):447-53. PubMed ID: 15002743
[TBL] [
